Founders Financial Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,264
Closed -$266K 515
2025
Q1
$266K Sell
3,264
-400
-11% -$35.8K 0.02% 407
2024
Q4
$330K Sell
3,664
-1,857
-34% -$180K 0.03% 366
2024
Q3
$545K Sell
5,521
-907
-14% -$89.1K 0.05% 256
2024
Q2
$596K Buy
6,428
+858
+15% +$76.9K 0.06% 257
2024
Q1
$529K Buy
5,570
+337
+6% +$31.3K 0.06% 255
2023
Q4
$467K Buy
5,233
+101
+2% +$7.5K 0.05% 255
2023
Q3
$375K Sell
5,132
-100
-2% -$7.99K 0.05% 241
2023
Q2
$435K Buy
5,232
+476
+10% +$39.8K 0.06% 226
2023
Q1
$362K Buy
4,756
+363
+8% +$30.1K 0.05% 240
2022
Q4
$365K Buy
4,393
+450
+11% +$36.4K 0.06% 230
2022
Q3
$313K Buy
+3,943
New +$332K 0.06% 228

Other funds holding XBI